Advertisement

Topics

Evidera Company Profile

15:11 EDT 19th March 2019 | BioPortfolio

Evidera, a wholly owned subsidiary of Symphony Technology Group, is one of the preeminent commercial entities analyzing effectiveness, establishing evidence and substantiating the value of treatments within the global health industry through its market-leading portfolio of health economics, outcomes research, market access, data analytics and epidemiology services. Evidera partners with life sciences organizations worldwide to optimize the market access and commercial success of their products by leveraging unparalleled knowledge of the global payer and regulator landscape and by developing, capturing and communicating the clinical and economic evidence that clients require to successfully market their products. Our research and consulting services are driven by world-class science and thought leadership and leverage a unique combination of capabilities. www.evidera.com


News Articles [5 Associated News Articles listed on BioPortfolio]

Evidera: Market Access Consulting Services

With rigorous, evolving, and heterogeneous payer evaluation criteria, challenging price negotiations, and a dynamic competitive environment, manufacturers need to prepare their market access strategy ...

Meaningful Treatment Benefit from the Patient’s Perspective

Instant download of paper http://bit.ly/patient-perspective Have you been told by the U.S. Food and Drug Administration (FDA) to include the patient’s perspective about treatment benefit in your dru...

Bucher Versus Bayesian NMA Approaches for Indirect Treatment Comparisons: What Do HTA Agencies Want?

Evidera recently wrote a paper comparing two common types of NMA approaches to reimbursement for treatments. When considering potential reimbursement of a new treatment, Health Technology Assessment (...

New Trends in Drug Safety and the Growing Role of Real-World Evidence

Instant download of paper http://bit.ly/DrugSafetyRWE A renewed focus on drug safety has emerged with the increased number of approved drugs, greater availability of information, and more direct invol...

Machine Learning – Biopharma Applications and Overview of Key Steps for Successful Implementation

Evidera recently wrote an article on utilizing Machine Learning and Big Data to achieve better results. This article reviews applications that increase efficiency and allow more convincing value demon...

Drugs and Medications [0 Results]

None

PubMed Articles [0 Results]

None

Clinical Trials [0 Results]

None

Companies [1 Associated Companies listed on BioPortfolio]

Evidera

Evidera, a wholly owned subsidiary of Symphony Technology Group, is one of the preeminent commercial entities analyzing effectiveness, establishing evidence and substantiat...

More Information about "Evidera" on BioPortfolio

We have published hundreds of Evidera news stories on BioPortfolio along with dozens of Evidera Clinical Trials and PubMed Articles about Evidera for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Evidera Companies in our database. You can also find out about relevant Evidera Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topic

Nutrition
Within medicine, nutrition (the study of food and the effect of its components on the body) has many different roles. Appropriate nutrition can help prevent certain diseases, or treat others. In critically ill patients, artificial feeding by tubes need t...


Corporate Database Quicklinks



Searches Linking to this Company Record